Jagsonpal Pharmaceuticals Limited Share Price & Stock Analysis

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

Key Metrics

Current Price	₹201.74
Market Cap	₹1,354 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Pharmaceuticals > Pharmaceutical Products
P/E Ratio	32
Return on Equity	16.70%
52-Week Range	₹155.00 – ₹301.65
Beta (1Y)	0.21
Dividend Yield	1.98%

Business Segments

1. Manufacturing and Trading of Pharmaceutical Products-100%

Peer Companies

• Abbott India Ltd.
• Ajanta Pharma Limited
• Astrazeneca Pharma India Ltd.
• Pfizer Ltd.
• Eris Lifesciences Ltd
• Caplin Point Laboratories Ltdte
• Marksans Pharma Ltd.
• Strides Pharma Science Limited (Star)

Frequently Asked Questions

What is the current share price of Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited is trading at ₹201.74, with a market capitalisation of ₹1,354 Cr.

Which sector does Jagsonpal Pharmaceuticals Limited belong to?

Jagsonpal Pharmaceuticals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).

What are the key financial ratios of Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited has a P/E of 32 and a return on equity of 16.70%.